Global Site Management Organizations Market (2021 to 2035) - by Therapeutic Areas, Trial Phases, Clinical Trial Components, Type of Interventions and Key Geographies

News provided by

Dec 16, 2021, 14:30 ET

DUBLIN, Dec. 16, 2021 /PRNewswire/ -- The "Site Management Organizations Market by Therapeutic Areas, Trial Phases, Clinical Trial Components, Type of Interventions and Key Geographies: Industry Trends and Global Forecasts, 2021-2035" report has been added to ResearchAndMarkets.com's offering.

This report features an extensive study of the current market landscape and future potential of the site management organizations market. The study features an in-depth analysis, highlighting the capabilities of clinical trial site management service providers engaged in this domain.

Clinical trials form an integral part of the overall drug development process, enabling the necessary evaluation of the safety and efficacy of a drug candidate. Studies suggest that around 40% of the total investment made for the development of drug candidate is dedicated to clinical trials; this is equivalent to an expenditure of USD 78 billion annually. However, the conduct of such trials is often fraught with challenges, including scientific and operational complexity, concerns associated with recruitment and retention of suitable patients, issues related to data handling and increasingly stringent regulatory guidelines.

Further, owing to the inherent complexity of the overall process and involvement of several different stakeholders, these trials are prone to delays. In fact, over 80% of the clinical trials are delayed by at least one to six months, while only 10% of the studies are completed on time. Therefore, innovators in the pharmaceutical industry are constantly developing ways to improve the process of conducting clinical trials and managing research sites.

Amidst other alternatives, outsourcing various trial operations to a specialized service provider, such as site management organizations (SMOs), has emerged as a viable option for various developers. The advantages of engaging such specialized service providers are numerous and enable sponsors to meet their clinical research timelines. In addition, SMOs can facilitate rapid patient recruitment, reduce study timelines, and manage the entire clinical trial processes and administrative work for their clients. Moreover, drug/medical device developers, and even the contract research organizations (CROs), can employ the therapeutic and operational expertise, global site networks and well-established processes and tools offered by SMOs in order to carry out their clinical research and site management activities in a cost and time efficient manner.

Currently, around 250 companies claim to be actively providing clinical site management services to drug and medical device developers across the world. Recently, there has been a lot of activity within the site management market, primarily focused on consolidation of affiliated capabilities, service portfolio expansions and collaborations to extend geographical reach. The aforementioned developments may be attributed to the growing preference for one-stop-shops among sponsor companies, and the gradual acceptance of outsourcing as a viable and beneficial operating model for conducting clinical trials and managing research sites. With the growing complexity, as well as rise in the number of clinical trials being registered, the demand for SMOs is anticipated to grow at a steady pace in the coming years.

Amongst other elements, the report features:

A detailed review of the overall landscape of companies offering clinical trial site management services to various organizations, including CROs, and pharmaceutical, biotechnology and medical devices companies, along with information on their year of establishment, company size (in terms of employee count), location of headquarters and geographical reach of the companies. The chapter also covers details related to type of service(s) offered (site identification and selection, study feasibility, study protocol development, patient recruitment, patient retention, project management, regulatory support, clinical monitoring, site management, clinical trial data management, patient follow-up, real-time enquiry/information support, study contract, budget and expense management/contract negotiation, hiring/training study investigator, logistics management, quality control and quality assurance and others) and therapeutic expertise of service providers.
An insightful 22 representation of the competitiveness analysis of various service providers segregated into three peer groups based on location of their headquarters (North America, Europe, and Asia-Pacific and RoW). The companies were further distributed across the geographies, based on their employee count, into three categories, namely small (1-200 employees), mid-sized (201-500 employees) and large (>500 employees), highlighting the top players in this domain, based on their respective capabilities.
An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2016-2021 (till August). The various types of partnerships captured in our study include (in alphabetical order) acquisitions, clinical trial agreements, clinical trial site agreements, joint ventures, mergers, product/technology integration agreements, research agreements, service alliances, technology licensing agreements, technology utilization agreements and other related agreements. Further, the partnership activity in this domain has been analyzed based on various parameters, such as year of partnership, type of partnership, focus area and most active players (in terms of number of partnerships). It also highlights the regional distribution of the collaborations.
A detailed analysis of various investments received by players engaged in this domain during the period 2015-2021 (till August), based on several relevant parameters, such as year of investment, number of funding instances, amount invested, type of funding (grant, seed, venture capital, secondary offering, other equity, debt and others) and type of investor, along with information on the most active players (in terms of number of funding instances and amount raised), most active investors (in terms of number of funding instances) and geographical distribution (in terms of number of funding instances and amount invested).
An in-depth analysis of completed, ongoing and planned clinical studies during the period 2016-2021 (till August), to present clinical trial key insights, based on several relevant parameters, such as trial registration year, number of enrolled patients, trial status, trial phase, type of sponsor and geographical distribution of number of trials and enrolled patient population.
An informed estimate of the annual demand for clinical study participants, taking into account the target patient population in ongoing and planned clinical trials, sponsored by both industry and non-industry players.
Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) that offer various clinical trial site management services, across North America, Europe and Asia-Pacific. Each profile provides an overview of the company, featuring information on the year of establishment, number of employees, location of their headquarters, details related to its site management service portfolio, recent developments, and an informed future outlook.

Key Questions Answered

Who are the leading players in the clinical trial site management domain?
What is the relative competitiveness of different site management organizations?
What type of partnership models are commonly adopted by stakeholders in this industry?
What is the capital investments trend in site management organizations domain?
Which are the most active clinical trial centers?
What are the major market trends and driving factors that are likely to impact the growth of site management organizations market?
How is the current and future market opportunity likely to be distributed across key market segments?

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. COMPETITIVE LANDSCAPE

5. COMPANY COMPETITIVENESS ANALYSIS

6. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN NORTH AMERICA

7. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN EUROPE

8. COMPANY PROFILES: SITE MANAGEMENT ORGANIZATIONS IN ASIA-PACIFIC

9. PARTNERSHIPS AND COLLABORATIONS

10. FUNDING AND INVESTMENT ANALYSIS

11. KEY INSIGHTS FROM CLINICAL TRIAL ANALYSIS

12. ANALYSIS OF DEMAND FOR CLINICAL TRIAL PARTICIPANTS

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS

14. CONCLUDING REMARKS

15. EXECUTIVE INSIGHTS

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Companies Mentioned

23andMe
3H Medi Solution
3S Pharma
Accel Clinical Services
Accell Clinical Research
Accelovance
accerise
Access Clinical Research
Ace Research
ACI Clinical
Acrostar SMO
ACTG-CRO
Advanced Clinical
Aetion
Affiliated Clinical Research
AiCure
Alpha Oncology Research (AOR)
Altasciences
Amadeus Capital Partners
AmberCRO
American Liver Foundation
American Research Associates (ARA)
AmerisourceBergen
Analgesic Solutions
Andronovo Labs
Anteris Bio
Antev
Antidote
AOBiome Therapeutics
Apex Medical Research
APF Research
ApotheCom
Apptomics
Aptitude Health
Ardent Clinical Research Services
Asian Eye Institute
Associated Medical
Association of Clinical Research Professionals (ACRP)
AstraZeneca
Atlant Clinical
Aurum Clinical Research
AusTrials
AutoCruitment
Avacare
AXELLE Group
AXIM Biotechnologies
BBK Worldwide
Beijing Aisimo Medical Science and Technology
Beijing CTSMED
Beijing EasyTrial MedTech
Beijing Global Pharmaceutical Research (Acquired by EPS International)
Beijing Illness Challenge Foundation (ICF)
Best Clinical Practice
Bioclinica
Biomapas
Biomedical Advanced Research and Development Authority (BARDA)
Biomic Lifescience
Biosite Research
Box
BrainStorm Cell Therapeutics
Briban Invest
Bridge Clinical Research
BTC Network
Cactus Clinical Research
Calmark
Canadian Centre for Clinical Trials (CCCT)
Cardialysis
CaringKind
Caris Life Sciences
Carpathian Research
Catalyst Regulatory Services (Acquired by Veristat)
CCT Research
Central India Clinical Research Services (CICRS)
Centre International de Developpement Pharmaceutique (CIDP)
Chase Medical Research
ChiG
Chrondel
Cidara Therapeutics
Cinven
Clariness
Cliantha Research
Clin Sol
Clinade Clinical Research
Clinart MENA
ClinChoice
ClinEdge
Clinerion
Clinexa Life Sciences
Clinical Accelerator
Clinical Development Solutions (CDS)
Clinical Endpoints
Clinical Investigation Centre (University Malaya Medical Centre)
Clinical Research Fastrack
Clinical Research Partners
Clinical Trial Networking (CT-N)
Clinical Trials Management Solutions (CTMS)
ClinicalConnection
Clinipace
CLINISYD
Clinixir
ClinROtech
ClinSmart
Clinsol
Clinspire Research
Clintec
Clintract
ClinVax
Clinverse
ClinWin Research Services
CLS-Ukraine
CluePoints
CMIC Group
CMX Research
CNS Pharmaceuticals
COD Research
Comac Medical
COMPASS Pathways
Compass Research
Continuum Clinical
Cosmic Clinical Services
Credevo
Crestline Investors
CRO Pharmatrendz
Croissance Clinical Research
CROMSOURCE
CRS Clinical Research Services
CTC North
CTI Clinical Trial and Consulting Services
CTM
CX Partners
Cyclo Therapeutics
Cytespace
DAC Patient Recruitment Services
Datavant
DAVA Oncology
DaVita Clinical Research
Deep Lens
Deerfield Management
DEMEDICA
Devana Solutions
DFnet
Dimension Research
Direct Biologics
dMed
Duke Clinical Research Institute (DCRI)
eClinical Solutions
Edenwell Therapeutics
EDETEK
Effectus CTR
EGeen
Elligo Health Research
EMMES
emovis
Empower Capital
EPS Associates
EPS International
EQT
ERT
ESTERN Medical
Estudios Clinicos Latinoamerica (ECLA)
Ethicscare Clinical Research Services (ECRS)
EthosExcel
Everest Clinical Research
Evolution Research Group (ERG)
Experior
F2 Ventures
FARMEPO
FDAMap
Febo
FedDev Ontario
FHI Clinical
Fidelis Research
FOMAT Medical Research
Foundation Medicine
Free to Breathe
Frenova Renal Research
Fresenius Medical Care
Gaea
Gama CRO
GB Sciences
GCP Clinical Studies
GCP Research
G CURE Healthcare
GDD Experts
Genentech
General Atlantic
George Clinical
GIC
Global Clinical Trials
Goldman Sachs Asset Management International (GSAMI)
Gratisol Labs
GSK
GuideStar Research
Haihe Biopharma
Hatteras Venture Partners
Haxon Life Sciences
Healing Hands Clinical Research Services (HHCRS)
HealthVerity
Horizon Research
Hospital Alemao Oswaldo Cruz
EI Hospital de Especialidades Teodoro Maldonado Carbo
Hoth Therapeutics
hyperCORE International
I'rom Group
iCo Therapeutics
iDD Research Solutions
IKCON PHARMA
Illingworth Research Group
InClin
Incred CR
Indian Institute of Clinical Research & Management (IICRM)
Industrifonden
Infectious Disease Research Institute (IDRI)
InformedDNA
Innoplexus
Innovaderm
Innovate Research
Insignia Clinical Services (ICS)
INSPIRE
Integrity Capital Wealth Management
Inteliquet
International Research Networks (IRN)
Intouch Clinical Research Center
Intrinsic Imaging (Acquired by WCG)
Invicro
IPHARMA
IQVIA
ITOCHU
ITOCHU Technology Ventures
Johnson Clinical Research
Juno Research
Karyopharm Therapeutics
Klinar CRO
KlinEra
KMR Group
Komplett Clinical Research (KCR)
KPS Clinical Services
KV Clinical Research Services (KVCR)
Kyung Hee University Hospital
LEADS Clinical Research and Bio Services
Limbix
Linical Americas
Link Health
LITMUS
LiveRamp
LMC Manna Research
Lyft
MakroCare
Marshfield Clinic Research Institute
Mary Bird Perkins Cancer Center
Mayo Clinic
med fusion (Acquired by Quest Diagnostics)
Medable
MedAvante-ProPhase (Acquired by WCG)
MEDEX
Median Technologies
Medicor Research
Medicus Alliance
Medicus Health Partners
Medidata
Melanoma Research Alliance
MENE Health Group
Merck
Merck Global Health Innovation Fund (GHI)
Metrics Champion Consortium (MCC) (Acquired by WCG)
Mitsui
MMG
Molecular Templates
Montserrat Day Hospitals
MPM Capital
MPR Development Group
MTIP
Muscular Dystrophy Association (MDA)
National Cancer Center
National Institute of Clinical Research (NICR)
National Taiwan University Hospital (NTUH)
NeoGenomics
Newton Clinical Research
NextPhase Research
Nomad Life Sciences
North Estonia Medical Centre
Novotech
nRollmed
Nucleon Therapeutics
O4 Research
Oaxaca Site Management Organization (OSMO)
Octopus Investments
Octopus Ventures
Okogen
OneOncology
Optimum CRO
Ora
Oracle
orphan reach
Orphanos
Ospedale San Raffaele
P3 Research
Panthera
Parallel 6 (Acquired by PRA Health Sciences)
Parexel
PAS Research
PatientPoint
Peachtree BioResearch Solutions
Penta ID Innovation
Pepgra
Pfizer
Pharmatech
Pharm-Olam
phaware
Physicians Research Group (PRG)
Plexus Research
Polaris Biopharma Consulting
PPC Group
PPD
Prabhans Clinical Services
Praxis
Precision for Medicine
Precision Health
Prime Site
Prodia
Protocol First
ProTrials Research
Prudentia
Psilera
Puerto Rico Consortium for Clinical Investigation (PRCCI)
Pulse Clinical Research
Pusan National University Hospital (PNUH)
PWNHealth
QAscent Research Solutions
QPS
Quad-C Management
Quanticate
Quantime World
Quest Diagnostics
Quintessential Solutions
Ravek
RealTime Software Solutions
Red Maple Trials
RemediumOne
Research Trials Group
RESolutions
Reumalab
Revive Therapeutics
Richmond Behavioral Associates (RBA)
Rock Springs Capital
Rutherford Health plc
S4 Research
Sabre Partners
Samahitha Research Solutions
Sandia Clinical Research
Sanjeevani
Sanofi
Santa Maria Gastroenterology
Scandinavian CRO
S-Clinical
SDS Clinical
Sequoia Capital
SGS Life Science Services
Shanghai Shoujia Medical Clinical Research
SiChaGi Medical Solutions
SIGAL SMS
Signify Health
SitePartner
Skin Research Institute of Singapore (SRIS)
Skylight Health
Smedvig Capital
SMO - DRA. MARISA VICO
SMO Clinical Research (SMO-India)
SMO ClinPlus
SMO UCT
SMOconnect
Smooth Drug Development
SMO-Pharmina
Society for Clinical Research Sites
Solutions OP
Somaya Research and Health Services
SoMex Research & Health Organisation
Sonic Clinical Trials
Spectral Medical
Spectrum Clinical Research
Spero Oncology (Acquired by Veristat)
SPRI Ukraine
Springhill Fund
SQN Clinical
Statistics Collaborative
Superstring Capital
Surescripts
Syncretic Clinical Research Services
Syneos Health
Syntax
Synteract
Syreon
Takeda Pharmaceutical
Terveystalo
TFS HealthScience
Association of Clinical Research Professionals (ACRP)
The Buffalo-Niagara Clinical Alliance (BNCA)
The Clinical Trial Company (TCTC) (Acquired by Veristat)
The Clinic'les
THREAD
ThreeWire
Tigermed
Tiziana Life Sciences
Topstone Research
Total Clinical Trial Management
Translational Research in Oncology (TRIO)
Trial Management Group (TMG)
Trialbee
TrialSpark
Trifecta (acquired by WCG)
TriNetX
Triumph Research Intelligence (TRI)
Triumpharma
United States Department of Defense (DOD)
uMotif
Unicorn Protego Site Management Organization (UP SMO)
United BioSource (UBC)
University of Yamanshi
Urgent Care Clinical Trials
Vector Oncology
Veeda Clinical Research
Veeva Systems
VeraSci
Veristat
Vicore Pharma
Vigilare International
Viomedo
Virgo
Walter and Eliza Hall Institute of Medical Research (WEHI)
WCCT Global
WCG
WCG Avoca
WCG PharmaSeek
WindRose Health Investors
Worldwide Clinical Trials
WuXi Clinical (a WuXi AppTec Company)
Xcene Research
Xylem Clinical Research
Zagvo Portal
Zarta Life
Zosano Pharma

For more information about this report visit https://www.researchandmarkets.com/r/xtf7y6

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets